Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilenia Segatto

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Oncogene|August 28, 2020
Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cellsValentina Ranzuglia, Ilaria Lorenzon, Ilenia Pellarin, et al.
Journal of Molecular Cell Biology|August 1, 2013
Inhibition of breast cancer local relapse by targeting p70S6 kinase activityIlenia Segatto, Stefania Berton, Maura Sonego, et al.
NPJ Breast Cancer|January 6, 2024
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in miceAndrea Favero, Ilenia Segatto, Alessandra Capuano, et al.
Cancer Research|December 22, 2019
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast CancerFrancesca Citron, Ilenia Segatto, Gian Luca Rampioni Vinciguerra, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 14, 2025
miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulationGiorgia Scafetta, Gian Luca Rampioni Vinciguerra, Simona Giglio, et al.
Cancer Communications (London, England)|June 20, 2023
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulationIlenia Segatto, Gian Luca Rampioni Vinciguerra, Ilenia Pellarin, et al.
Science Advances|November 13, 2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activityAnna Nespolo, Linda Stefenatti, Ilenia Pellarin, et al.
Nature Communications|October 25, 2023
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growthCamilla Tombari, Alessandro Zannini, Rebecca Bertolio, et al.
Nature Communications|November 6, 2023
Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growthCamilla Tombari, Alessandro Zannini, Rebecca Bertolio, et al.
Cancer Research|November 7, 2025
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast CancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Oncogene|August 28, 2020
Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cellsValentina Ranzuglia, Ilaria Lorenzon, Ilenia Pellarin, et al.
Journal of Molecular Cell Biology|August 1, 2013
Inhibition of breast cancer local relapse by targeting p70S6 kinase activityIlenia Segatto, Stefania Berton, Maura Sonego, et al.
NPJ Breast Cancer|January 6, 2024
Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in miceAndrea Favero, Ilenia Segatto, Alessandra Capuano, et al.
Cancer Research|December 22, 2019
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast CancerFrancesca Citron, Ilenia Segatto, Gian Luca Rampioni Vinciguerra, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 14, 2025
miR-1297 is frequently downmodulated in flat epithelial atypia of the breast and promotes mammary neoplastic transformation via EphrinA2 regulationGiorgia Scafetta, Gian Luca Rampioni Vinciguerra, Simona Giglio, et al.
Cancer Communications (London, England)|June 20, 2023
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulationIlenia Segatto, Gian Luca Rampioni Vinciguerra, Ilenia Pellarin, et al.
Science Advances|November 13, 2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activityAnna Nespolo, Linda Stefenatti, Ilenia Pellarin, et al.
Nature Communications|October 25, 2023
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growthCamilla Tombari, Alessandro Zannini, Rebecca Bertolio, et al.
Nature Communications|November 6, 2023
Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growthCamilla Tombari, Alessandro Zannini, Rebecca Bertolio, et al.
Cancer Research|November 7, 2025
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast CancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.
Pageof 4